The Schwyz startup Oviva has been able to raise US$80 million in a Series C financing round, as was reported in a press release. The round was co-led by investment company Sofina from Belgium and Temasek from Singapore. It also included existing investors and several angel investors.
Oviva offers technology-supported nutritional advice from expert health care professionals. To achieve this, the startup draws on a network of nutritionists and advisory technology. This enables personalized diet and lifestyle coaching to be offered via a smartphone app. Oviva’s solution above all aims to help people with health issues like diabetes and obesity.
Founded in 2014, the startup has formed over 5,000 partnerships with health systems, insurers and doctors. To date, the business has helped over 200,000 people with diet-related challenges all over Europe, namely in the UK, Germany, Switzerland and France. Last year, Oviva more than doubled both the number of people treated and the revenue earned.
The funding will help Oviva to expand. “On the one hand, we are keen to enable existing employees to take over more responsibility. And, on the other hand, we are searching for new talent to join us on our journey to help our existing and new patients achieve better health and well-being,” said Kai Eberhardt, CEO and co-founder of Oviva. Specifically, the startup intends to grow its team to 800 employees by the end of 2022. Oviva will also be looking at potential M&A opportunities to further grow the business.
